| Literature DB >> 32635927 |
Alireza Mirsharifi1, Mohammad Vasei2, Ehsan Sadeghian1, Ali Ghorbani-Abdehgah3, Sara Naybandi Atashi4.
Abstract
BACKGROUND: Adrenocortical carcinoma is a rare malignancy, with 43% being non-functional. These may arise from adrenal rest anywhere in the embryonic pathway of the adrenal glands. In the context of extra-adrenal and retroperitoneal tumors, the exact pathologic diagnosis is challenging. The case reported here, to the best of our knowledge, is the seventh reported case of extra-adrenal non-functional adrenocortical carcinoma. CASEEntities:
Keywords: Acute abdomen; Adrenocortical carcinoma; Children; Mitotane
Mesh:
Substances:
Year: 2020 PMID: 32635927 PMCID: PMC7341564 DOI: 10.1186/s13256-020-02408-7
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Immunohistochemistry findings
| Marker | Interpretation |
|---|---|
| Pan cytokeratin AE1/AE3 | Negative |
| SF-1 (steroidogenic factor 1) | Diffusely positive |
| Synaptophysin | Diffusely positive |
| Alpha inhibin | Focally positive |
| Melan A | Diffusely positive |
| PAX8 (paired-box gene) | Negative |
| EMA (epithelial membrane antigen) | Negative |
| Chromogranin | Negative |
| S100 protein | Positive in a few tumor cells |
| CD10 | Negative |
| Vimentin | Negative |
| Calretinin | Positive |
| Ki-67 protein | 6% |
| HMB45 (human melanoma black 45) | negative |
Fig. 1Normal appearance of adrenal glands is evident in postoperation computed tomography scan shown with arrow (after tumor resection and before adrenalectomy)
Extra-adrenal non-functional adrenocortical carcinomas
| Author(s) and reference number | Age (year) and sex | Size | Location | Management | Follow up |
|---|---|---|---|---|---|
| Current case | 15 M | 8 cm | In retroperitoneum at the medial side of the right kidney | Resection followed by mitotane | NED at 30 m |
| Cornejo | 51 M | 10 cm | Pelvic mass arising within the soft tissue between the prostate and bladder | Resection followed by mitotane and RT | NED at 9 m |
| Bani-Hani [ | 52 M | 19 cm | Mass lying between spleen, stomach, tail of pancreas, splenic flexure and left kidney and adrenal gland | Resection | NED at 25 m |
| Rodriguez | 0.4 F | 6 cm | Spinal cord at T10–L2 | Laminectomy with gross total resection | LR at 6 m s/p second gross total resection, undergoing chemotherapy (cisplatin, doxorubicin, etoposide, mitotane) 5 m postoperation |
| Goren | 50 F | 8 cm | Hilum of left kidney | Radical nephrectomy | NED at 12 m |
| Yokoyama | 34 F | 6.5 cm | Retroperitoneum | Retroperitoneal mass between right kidney and IVC resection | Resection NED at 120 m |
| Lee | 61 M | 13 cm | Right intrarenal | Adjuvant chemotherapy (VAP; vincristine, doxorubicin, and prednisolone) with mitotane | NED at 3 m |
F female, IVC inferior vena cava, LR local recurrence, M male, m month, NED no evidence of disease, RT radiotherapy, s/p status post
Fig. 2Immunohistochemistry for steroidogenic factor 1 (a) and synaptophysin (b) as well as Melan A (c) shows diffuse nuclear and cytoplasmic positive reactions respectively. α-inhibin positivity was focal (d) 3,3'-diaminobenzidine staining × 400